21.05.2014 Views

Pediatric Terrorism and Disaster Preparedness: A ... - PHE Home

Pediatric Terrorism and Disaster Preparedness: A ... - PHE Home

Pediatric Terrorism and Disaster Preparedness: A ... - PHE Home

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

primitive/progenitor cells <strong>and</strong> other rapidly dividing cells, while slower growing <strong>and</strong><br />

more mature cells are generally radio-resistant. The most radiosensitive mammalian cells,<br />

in decreasing order, include the following:<br />

• Spermatogonia.<br />

• Lymphocytes <strong>and</strong> oocytes.<br />

• Erythroblasts.<br />

• Other hematopoietic tissue.<br />

• Small-intestine crypt cells.<br />

• Hair follicles.<br />

All of these cells contain rapidly dividing cell lines. Clinicians are familiar with the<br />

effects of radiotherapy <strong>and</strong> chemotherapy on these tissues, as sterility, bone marrow<br />

damage, diarrhea, <strong>and</strong> hair loss all involve radiosensitive stem cell lines. With survivable<br />

radiation doses, some stem cells survive, <strong>and</strong> their cell lines regenerate. Microvascular<br />

injury can result in dramatic systemic symptoms <strong>and</strong> in permanent <strong>and</strong> irreversible<br />

damage such as local radiation injury.<br />

Clinically detectable effects first appear at doses >0.2 Gy (≥20 cGy or 20 rad). These<br />

effects include decreased sperm count, chromosome abnormalities, <strong>and</strong> mild bone<br />

marrow depression. Whole-body radiation doses >0.7 Gy can cause clinical illness. The<br />

lethal dose 50 (LD 50 ) for penetrating radiation is approximately 3.5 Gy for untreated<br />

patients <strong>and</strong> 5 Gy for those receiving full medical treatment. The LD 50 is the dose of<br />

radiation that will kill half the exposed population.<br />

Clinical Stages<br />

All health effects from radiation exposure tend to follow a similar clinical pattern that can<br />

be divided into a series of time-dependent stages: prodrome, latent period, <strong>and</strong> manifest<br />

illness. At higher radiation doses, these stages are associated with shorter time of onset,<br />

more severe signs <strong>and</strong> symptoms, <strong>and</strong> decreased survival. However, there is individual<br />

variation, <strong>and</strong> symptoms may not occur in all patients.<br />

Prodrome. The initial stage of prodromal symptoms (prodrome) begins within the first<br />

few hours to 2 days after exposure. Symptoms include nausea <strong>and</strong> vomiting, with<br />

subsequent malaise, fatigue, <strong>and</strong> weakness. This is a nonspecific clinical response to<br />

acute radiation exposure caused by the cell membrane <strong>and</strong> free-radical effects of radiation<br />

energy, as mediator chemicals such as histamine, interleukins, <strong>and</strong> cytokines are released.<br />

Latent period. On recovery from the prodrome, there is usually a latent period during<br />

which most symptoms subside, although fatigue <strong>and</strong> weakness may remain.<br />

Manifest illness. This is the full disease picture that develops from the clinical signs <strong>and</strong><br />

symptoms associated with damage to major organ systems (e.g., blood-forming elements,<br />

intestine, cardiovascular, CNS). The molecular cause of disease is DNA damage. Death is<br />

usually caused by sepsis.<br />

163

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!